Company: BLRX
Filing Date: 2025-03-31
Form Type: 20-F
Source: 0001178913-25-001123
Chunk: 254

Company: BioLineRx Ltd.
Filing Date: 2025-03-31
Form: 20-F
Item: Item 8
Chunk 254
---
-back) if the company
does not meet the profit test without seeking the approval of the court, subject to the following: (i) the company meets the solvency
test; and (ii) we provide a notice to certain creditors regarding our intention to distribute a dividend by way of a share repurchase
program in accordance with the notice requirements set forth in the Relief Regulations and no such creditor submits an objection within
30 days of the notice (otherwise, court approval would be required for such distribution in accordance with the requirements of the Companies
Law). For information regarding taxation of dividends, see “ Item 10E. Additional Information - Taxation - Israeli Tax
Considerations.”

B. Significant Changes

None.

ITEM 9. THE OFFER AND
LISTING

A. Offer and Listing Details

Our ADSs have been trading on Nasdaq under the symbol “ BLRX”
since July 2011. Our ordinary shares have been trading on the TASE under the symbol “ BLRX” since February 2007.

B. Plan of Distribution

Not applicable.

C. Markets

Our ADSs trade on Nasdaq under the symbol “ BLRX.” Our
ordinary shares trade on the TASE under the symbol “ BLRX.”

D. Selling Shareholders

Not applicable.

E. Dilution

Not applicable.

F. Expenses of the Issue

Not applicable.

92

ITEM 10. ADDITIONAL
INFORMATION

A. Share Capital

Not applicable.

B. Articles of Association

A copy of our Articles of Association is attached as Exhibit 1.1
to this Annual Report on Form 20-F. Other than as set forth below, the information called for by this Item is set forth in Exhibit 2.2
to this Annual Report on Form 20-F and is incorporated by reference into this Annual Report on Form 20-F.

Board of Directors

See “ Item 6. Directors, Senior Management and Employees — C. Board Practices.”

Borrowing Powers

Pursuant to the Companies Law and our Articles of Association,
our board of directors may exercise all powers and take all actions that are not required under law or under our Articles of Association
to be exercised or taken by our shareholders, including the power to borrow money for company purposes.

Shareholder Meetings

Under the Companies Law, annual general meetings of shareholders
are required to be held at least once in every calendar year (within 15 months after the last preceding annual general meeting of shareholders).
All general meetings other than the